AU2001276392A1 - Vaccine comprising a lung tumour associated antigen - Google Patents

Vaccine comprising a lung tumour associated antigen

Info

Publication number
AU2001276392A1
AU2001276392A1 AU2001276392A AU7639201A AU2001276392A1 AU 2001276392 A1 AU2001276392 A1 AU 2001276392A1 AU 2001276392 A AU2001276392 A AU 2001276392A AU 7639201 A AU7639201 A AU 7639201A AU 2001276392 A1 AU2001276392 A1 AU 2001276392A1
Authority
AU
Australia
Prior art keywords
vaccine
associated antigen
tumour associated
lung tumour
lung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276392A
Other languages
English (en)
Inventor
Jean-Pol Cassart
Swann Gaulis
Carlota Vinals Y De Bassols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Publication of AU2001276392A1 publication Critical patent/AU2001276392A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001276392A 2000-07-17 2001-07-11 Vaccine comprising a lung tumour associated antigen Abandoned AU2001276392A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0017512 2000-07-17
GBGB0017512.5A GB0017512D0 (en) 2000-07-17 2000-07-17 Novel compounds
PCT/EP2001/007967 WO2002006338A1 (fr) 2000-07-17 2001-07-11 Vaccin comprenant un antigene associe a une tumeur du poumon

Publications (1)

Publication Number Publication Date
AU2001276392A1 true AU2001276392A1 (en) 2002-01-30

Family

ID=9895804

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276392A Abandoned AU2001276392A1 (en) 2000-07-17 2001-07-11 Vaccine comprising a lung tumour associated antigen

Country Status (3)

Country Link
AU (1) AU2001276392A1 (fr)
GB (1) GB0017512D0 (fr)
WO (1) WO2002006338A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201319446D0 (en) 2013-11-04 2013-12-18 Immatics Biotechnologies Gmbh Personalized immunotherapy against several neuronal and brain tumors
GB201520592D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
SG11201906198PA (en) * 2017-01-27 2019-08-27 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
AU2018305923B2 (en) * 2017-07-25 2022-05-05 Idp Discovery Pharma, S.L. Anticancer peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087168A (en) * 1999-01-20 2000-07-11 Cedars Sinai Medical Center Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells

Also Published As

Publication number Publication date
WO2002006338A1 (fr) 2002-01-24
GB0017512D0 (en) 2000-08-30

Similar Documents

Publication Publication Date Title
AU2002336760A1 (en) Mutable vaccines
GB0020953D0 (en) Vaccine
HUP0301092A3 (en) Vaccine
IL155072A0 (en) Vaccine
AU2001258279A1 (en) Adjuvant for vaccines
AU1591402A (en) Vaccine
AU2001290860A1 (en) Spas-1 cancer antigen
AU2002349543A1 (en) Tumor antigens
GB0014288D0 (en) Vaccine
AU2003289603A1 (en) Tumor vaccine
AU2001276392A1 (en) Vaccine comprising a lung tumour associated antigen
AU2002249823A1 (en) Acne vaccine
EP1454914A4 (fr) Antigene de tumeur
GB0014845D0 (en) Vaccine
GB0026334D0 (en) Vaccine
GB0025694D0 (en) Vaccine
AU2002321882A1 (en) Multivalent synthetic vaccine for cancer
EP1403283A4 (fr) Antigenes tumoraux
AU2001266534A1 (en) Papillomavirus vaccine
AU3397101A (en) Adjuvants
AUPQ865200A0 (en) Haemagglutinin antigen
AU5084300A (en) New vaccine formulations - 1
GB0015722D0 (en) Vaccine
GB0006693D0 (en) Vaccine
AU2001285773A1 (en) Vaccine